Target intelligence / Profile preview

MicroRNA 4285 (MIR4285)

Target
MIR4285
Molecular classification
MicroRNA, non-coding RNA
01

Overview

MicroRNA 4285 (MIR4285) is a member of the microRNA family of small, non-coding RNAs that regulate gene expression at the post-transcriptional level via base-pairing with complementary sequences in target mRNAs, leading to mRNA degradation or inhibition of translation. MicroRNAs, including MIR4285, are critical for fine-tuning the expression of multiple genes and thus participate in a wide array of cellular regulatory networks. Although microRNAs as a class are involved in many diseases and biological processes, there is currently no published information detailing the role, disease associations, or therapeutic targeting of MIR4285. Commercially available synthetic mimics exist for functional research purposes. If further research emerges associating MIR4285 with specific diseases, drug interactions, or therapeutic development, this classification may change accordingly.

Other names
hsa-mir-4285MIR4285microRNA 4285
02

Mechanism of action

Not applicable—MIR4285 itself is not a drug target. In research, mimics of the miRNA upregulate its function to investigate its effects on cellular processes.

03

Biological functions

Gene regulation (post-transcriptional)RNA silencingControl of protein expression
04

Disease associations

No specific disease associations or roles are documented in the current literature for MIR4285. Most described miRNAs, as a class, are implicated in several diseases, especially cancer, via dysregulation of their gene targets. For MIR4285, specific data is lacking.
05

Safety considerations

None reported. General therapeutic targeting of miRNAs can have safety concerns due to their broad regulatory roles, but no such concerns have been articulated for MIR4285.
06

Interacting drugs

None reported. There are commercially available mimics of hsa-miR-4285 used in research, which are synthetic molecules designed to replicate its activity for functional studies. These are not therapeutic drugs.
07

Biomarkers

None reported. Other miRNAs are widely used as biomarkers in cancer and other diseases, but MIR4285 does not feature in current biomarker panels.

Beyond the preview

Go deeper on MicroRNA 4285 (MIR4285).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4285 (MIR4285).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call